Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer

Clinical trial NCT00096395 · COMPLETED

Trial details

NCT number: NCT00096395
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Ovarian Epithelial Cancer Recurrent Primary Peritoneal Cavity Cancer

Start date: 2004-09-01
Primary completion: 2007-02-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.